搜尋





搜尋





市場行情
/
股票
/
atra
/

Atara Biotherapeutics Inc

ATRA

添加自選

8.380USD

+0.210+2.57%

收盤 07-31 16:00（美東）報價延遲15分鐘

60.42M總市值

虧損本益比TTM

Atara Biotherapeutics Inc

8.380

+0.210+2.57%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

ATRA 利潤表

您可以在這裡找到Atara Biotherapeutics Inc的年度或季度收入報告，以深入了解Atara Biotherapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q4

FY2014Q3

FY2014Q2

FY2014Q1

FY2013Q2

FY2013Q1

營業總收入

-99.47%516.00K

-95.13%1.59M

-91.41%3.45M

-38.63%17.57M

258.77%98.15M

670.30%32.75M

1779.79%40.19M

2892.69%28.64M

2131.40%27.36M

1823.98%4.25M

-52.05%2.14M

-98.14%957.00K

-83.24%1.23M

-97.07%221.00K

-16.96%4.46M

1232.79%51.58M

105.91%7.31M

--7.55M

--5.37M

--3.87M

--3.55M

----

--0.00

----

--0.00

營業收入

-99.47%516.00K

-95.13%1.59M

-91.41%3.45M

-38.63%17.57M

258.77%98.15M

670.30%32.75M

1779.79%40.19M

2892.69%28.64M

2131.40%27.36M

1823.98%4.25M

-52.05%2.14M

-98.14%957.00K

-83.24%1.23M

-97.07%221.00K

-16.96%4.46M

1232.79%51.58M

105.91%7.31M

--7.55M

--5.37M

--3.87M

--3.55M

----

--0.00

主營業務成本

-99.39%124.00K

-98.47%104.00K

-98.49%115.00K

-88.03%554.00K

929.67%20.44M

115.03%6.79M

190.71%7.60M

59.83%4.63M

818.98%1.98M

--3.16M

--2.62M

--2.90M

--216.00K

----

營業費用

-91.45%3.88M

-93.52%2.91M

-88.70%7.00M

-72.36%12.86M

-15.63%45.43M

-21.86%44.96M

-13.66%61.95M

-35.73%46.52M

-29.33%53.85M

-23.99%57.53M

-13.75%71.75M

-13.55%72.37M

-20.24%76.20M

-25.03%75.69M

-7.75%83.19M

-4.74%83.71M

16.79%95.53M

23.57%100.95M

20.72%90.18M

12.73%87.87M

9.51%81.80M

2.51%81.70M

2.96%74.71M

3.20%77.95M

10.02%74.70M

-2.59%79.70M

20.48%72.56M

43.54%75.53M

59.92%67.89M

128.52%81.82M

90.21%60.22M

88.55%52.62M

62.27%42.45M

90.90%35.80M

22.04%31.66M

43.23%27.91M

53.34%26.16M

-13.85%18.75M

111.62%25.94M

28.97%19.48M

83.23%17.06M

105.45%21.77M

106.07%12.26M

233.22%15.11M

31.57%9.31M

--10.60M

--5.95M

233.14%4.53M

450.31%7.08M

--1.36M

--1.29M

研發費用

-98.91%164.00K

-99.36%185.00K

-93.37%2.91M

-80.70%6.37M

-64.42%14.98M

-34.70%28.72M

-22.79%43.92M

-41.26%32.98M

-32.25%42.11M

-29.83%43.98M

-15.66%56.89M

-13.49%56.14M

-17.08%62.16M

-20.79%62.68M

-4.10%67.45M

-5.22%64.90M

17.02%74.96M

20.72%79.13M

17.46%70.33M

11.23%68.47M

11.10%64.06M

6.35%65.55M

11.84%59.88M

17.82%61.56M

18.47%57.66M

-0.99%61.64M

23.49%53.54M

56.50%52.25M

71.00%48.67M

151.32%62.26M

110.48%43.35M

82.48%33.39M

62.25%28.46M

83.84%24.77M

9.55%20.60M

40.84%18.30M

55.96%17.54M

-16.99%13.47M

131.75%18.80M

12.90%12.99M

95.02%11.25M

221.53%16.23M

91.30%8.11M

262.31%11.51M

93.46%5.77M

--5.05M

--4.24M

458.17%3.18M

742.09%2.98M

--569.00K

--354.00K

折舊攤銷及損耗

-98.38%29.00K

-90.91%100.00K

-97.07%36.00K

-82.26%236.00K

29.04%1.79M

-8.71%1.10M

1.74%1.23M

10.74%1.33M

14.58%1.39M

-7.31%1.21M

-13.64%1.21M

-16.48%1.20M

-23.70%1.21M

-50.83%1.30M

-40.68%1.40M

-37.96%1.44M

-28.40%1.59M

22.58%2.64M

7.27%2.36M

10.38%2.32M

16.95%2.22M

9.27%2.16M

16.83%2.20M

11.46%2.10M

15.29%1.90M

33.56%1.97M

58.24%1.88M

157.73%1.88M

394.89%1.65M

431.65%1.48M

376.00%1.19M

229.28%731.00K

61.65%333.00K

60.69%278.00K

90.84%250.00K

246.88%222.00K

1273.33%206.00K

540.74%173.00K

1210.00%131.00K

1180.00%64.00K

150.00%15.00K

1250.00%27.00K

400.00%10.00K

305.19%5.00K

438.12%6.00K

--2.00K

23.40%1.23K

11.50%1.11K

--1.00K

其他營業費用

----

---745.00K

----

營業利潤

-106.39%-3.37M

89.21%-1.32M

83.70%-3.55M

126.41%4.72M

298.95%52.72M

77.10%-12.20M

68.75%-21.76M

74.97%-17.88M

64.66%-26.50M

29.40%-53.28M

11.58%-69.61M

-122.25%-71.41M

15.02%-74.97M

19.20%-75.47M

7.17%-78.73M

61.75%-32.13M

-12.75%-88.22M

-14.33%-93.40M

-13.53%-84.81M

-7.76%-84.00M

-4.75%-78.25M

-2.51%-81.70M

-2.96%-74.71M

-3.20%-77.95M

-10.02%-74.70M

2.59%-79.70M

-20.48%-72.56M

-43.54%-75.53M

-59.92%-67.89M

-128.52%-81.82M

-90.21%-60.22M

-88.55%-52.62M

-62.27%-42.45M

-90.90%-35.80M

-22.04%-31.66M

-43.23%-27.91M

-53.34%-26.16M

13.85%-18.75M

-111.62%-25.94M

-28.97%-19.48M

-83.23%-17.06M

-105.45%-21.77M

-106.07%-12.26M

-233.22%-15.11M

-31.57%-9.31M

---10.60M

---5.95M

-233.14%-4.53M

-450.31%-7.08M

---1.36M

---1.29M

淨非營業利息收入（費用）

利息收入

-77.12%54.00K

-83.25%100.00K

-55.56%204.00K

-68.22%143.00K

-60.93%236.00K

-16.03%597.00K

-62.32%459.00K

-73.45%450.00K

-66.48%604.00K

-26.63%711.00K

125.14%1.22M

369.53%1.69M

1466.96%1.80M

1053.57%969.00K

265.54%541.00K

60.44%361.00K

--115.00K

-78.89%84.00K

-59.34%148.00K

-54.73%225.00K

----

-67.24%398.00K

-44.93%364.00K

-58.82%497.00K

-27.29%1.19M

-30.85%1.22M

-64.44%661.00K

-30.75%1.21M

61.94%1.63M

271.46%1.76M

229.61%1.86M

262.37%1.74M

98.23%1.01M

-8.86%473.00K

-2.08%564.00K

-20.50%481.00K

1.19%509.00K

-0.57%519.00K

51.58%576.00K

271.17%605.00K

228.76%503.00K

690.91%522.00K

1166.67%380.00K

608.70%163.00K

2450.00%153.00K

--66.00K

--30.00K

475.00%23.00K

200.00%6.00K

--4.00K

--2.00K

利息費用

-18.39%830.00K

-12.09%894.00K

-23.16%909.00K

-22.98%972.00K

-11.80%1.02M

-13.52%1.02M

1905.08%1.18M

901.59%1.26M

773.48%1.15M

--1.18M

--59.00K

--126.00K

--132.00K

----

出售證券收益

----

---1.34M

---1.25M

---1.20M

----

特殊收入（費用）

----

---1.25M

---27.00K

-327.81%-1.52M

-192.84%-13.91M

100.00%0.00

--0.00

---356.00K

-10457.78%-4.75M

-8933.78%-6.69M

100.00%0.00

--0.00

---45.00K

---74.00K

---5.89M

----

--0.00

----

--0.00

-固定資產出售收益

----

--0.00

-100.00%0.00

----

--0.00

--50.24M

----

其他非經營性收入（費用）

100.00%0.00

44.94%-49.00K

-99.28%4.00K

466.67%22.00K

-116.18%-11.00K

-641.67%-89.00K

2155.56%555.00K

40.00%-6.00K

134.52%68.00K

---12.00K

---27.00K

---10.00K

---197.00K

----

稅前利潤

-110.91%-4.14M

73.21%-3.41M

80.50%-4.28M

112.55%2.39M

219.80%38.01M

78.97%-12.71M

68.59%-21.93M

73.21%-19.05M

57.55%-31.73M

18.95%-60.44M

16.97%-69.82M

-485.07%-71.11M

15.16%-74.75M

20.09%-74.57M

0.69%-84.08M

122.04%18.47M

-12.47%-88.11M

-14.78%-93.32M

-13.88%-84.66M

-8.16%-83.78M

-6.57%-78.33M

-3.59%-81.30M

-3.40%-74.34M

-4.21%-77.45M

-10.95%-73.51M

1.97%-78.48M

-23.19%-71.89M

-46.08%-74.33M

-59.88%-66.26M

-126.61%-80.06M

-87.68%-58.36M

-85.50%-50.88M

-61.56%-41.44M

-93.74%-35.33M

-22.59%-31.10M

-45.28%-27.43M

-54.92%-25.65M

14.18%-18.23M

-113.54%-25.37M

-26.33%-18.88M

-80.80%-16.56M

-101.79%-21.25M

-100.69%-11.88M

-231.30%-14.95M

-29.51%-9.16M

---10.53M

---5.92M

-232.42%-4.51M

-450.70%-7.07M

---1.36M

---1.28M

所得稅

--0.00

100.00%0.00

264.71%28.00K

--3.00K

-100.00%0.00

-272.73%-19.00K

10.53%-17.00K

-100.00%0.00

9.09%24.00K

450.00%11.00K

-290.00%-19.00K

--1.00K

--22.00K

-93.33%2.00K

--10.00K

-100.00%0.00

--0.00

275.00%30.00K

-100.00%0.00

1500.00%16.00K

----

-33.33%8.00K

--6.00K

--1.00K

----

125.53%12.00K

--0.00

-100.00%0.00

----

-193.75%-47.00K

--0.00

--3.00K

-100.00%0.00

---16.00K

-100.00%0.00

--0.00

-33.33%2.00K

--0.00

163.64%7.00K

--0.00

50.00%3.00K

100.00%0.00

---11.00K

--0.00

109.09%2.00K

---3.00K

--0.00

-100.00%0.00

-257.14%-22.00K

--26.00K

--14.00K

除稅後利潤

-110.91%-4.14M

73.17%-3.41M

80.36%-4.30M

112.53%2.39M

219.71%38.01M

79.00%-12.69M

68.61%-21.91M

73.21%-19.05M

57.53%-31.75M

18.94%-60.45M

17.00%-69.80M

-485.08%-71.11M

15.13%-74.77M

20.11%-74.57M

0.68%-84.09M

122.04%18.47M

-12.47%-88.11M

-14.81%-93.35M

-13.88%-84.66M

-8.18%-83.79M

-6.57%-78.33M

-3.58%-81.31M

-3.41%-74.35M

-4.21%-77.46M

-10.95%-73.51M

1.89%-78.50M

-23.19%-71.89M

-46.08%-74.33M

-59.88%-66.26M

-126.58%-80.01M

-87.68%-58.36M

-85.51%-50.88M

-61.55%-41.44M

-93.66%-35.31M

-22.56%-31.10M

-45.28%-27.43M

-54.91%-25.65M

14.18%-18.23M

-113.79%-25.37M

-26.33%-18.88M

-80.80%-16.56M

-101.84%-21.25M

-100.51%-11.87M

-231.30%-14.95M

-29.95%-9.16M

---10.53M

---5.92M

-226.17%-4.51M

-443.07%-7.05M

---1.38M

---1.30M

持續經營利潤

-110.91%-4.14M

73.17%-3.41M

80.36%-4.30M

112.53%2.39M

219.71%38.01M

79.00%-12.69M

68.61%-21.91M

73.21%-19.05M

57.53%-31.75M

18.94%-60.45M

17.00%-69.80M

-485.08%-71.11M

15.13%-74.77M

20.11%-74.57M

0.68%-84.09M

122.04%18.47M

-12.47%-88.11M

-14.81%-93.35M

-13.88%-84.66M

-8.18%-83.79M

-6.57%-78.33M

-3.58%-81.31M

-3.41%-74.35M

-4.21%-77.46M

-10.95%-73.51M

1.89%-78.50M

-23.19%-71.89M

-46.08%-74.33M

-59.88%-66.26M

-126.58%-80.01M

-87.68%-58.36M

-85.51%-50.88M

-61.55%-41.44M

-93.66%-35.31M

-22.56%-31.10M

-45.28%-27.43M

-54.91%-25.65M

14.18%-18.23M

-113.79%-25.37M

-26.33%-18.88M

-80.80%-16.56M

-101.84%-21.25M

-100.51%-11.87M

-231.30%-14.95M

-29.95%-9.16M

---10.53M

---5.92M

-226.17%-4.51M

-443.07%-7.05M

---1.38M

---1.30M

歸属于母公司的淨利潤

-110.91%-4.14M

73.17%-3.41M

80.36%-4.30M

112.53%2.39M

219.71%38.01M

79.00%-12.69M

68.61%-21.91M

73.21%-19.05M

57.53%-31.75M

18.94%-60.45M

17.00%-69.80M

-485.08%-71.11M

15.13%-74.77M

20.11%-74.57M

0.68%-84.09M

122.04%18.47M

-12.47%-88.11M

-14.81%-93.35M

-13.88%-84.66M

-8.18%-83.79M

-6.57%-78.33M

-3.58%-81.31M

-3.41%-74.35M

-4.21%-77.46M

-10.95%-73.51M

1.89%-78.50M

-23.19%-71.89M

-46.08%-74.33M

-59.88%-66.26M

-126.58%-80.01M

-87.68%-58.36M

-85.51%-50.88M

-61.55%-41.44M

-93.66%-35.31M

-22.56%-31.10M

-45.28%-27.43M

-54.91%-25.65M

14.18%-18.23M

-113.79%-25.37M

-26.33%-18.88M

-80.80%-16.56M

-101.84%-21.25M

-100.51%-11.87M

-231.30%-14.95M

-29.95%-9.16M

---10.53M

---5.92M

-226.17%-4.51M

-443.07%-7.05M

---1.38M

---1.30M

歸屬普通股東的淨利潤

-110.91%-4.14M

73.17%-3.41M

80.36%-4.30M

112.53%2.39M

219.71%38.01M

79.00%-12.69M

68.61%-21.91M

73.21%-19.05M

57.53%-31.75M

18.94%-60.45M

17.00%-69.80M

-485.08%-71.11M

15.13%-74.77M

20.11%-74.57M

0.68%-84.09M

122.04%18.47M

-12.47%-88.11M

-14.81%-93.35M

-13.88%-84.66M

-8.18%-83.79M

-6.57%-78.33M

-3.58%-81.31M

-3.41%-74.35M

-4.21%-77.46M

-10.95%-73.51M

1.89%-78.50M

-23.19%-71.89M

-46.08%-74.33M

-59.88%-66.26M

-126.58%-80.01M

-87.68%-58.36M

-85.51%-50.88M

-61.55%-41.44M

-93.66%-35.31M

-22.56%-31.10M

-45.28%-27.43M

-54.91%-25.65M

14.18%-18.23M

-113.79%-25.37M

-26.33%-18.88M

-80.80%-16.56M

-101.84%-21.25M

-100.51%-11.87M

-231.30%-14.95M

-29.95%-9.16M

---10.53M

---5.92M

-226.17%-4.51M

-443.07%-7.05M

---1.38M

---1.30M

基本每股收益

-108.34%-0.29

78.90%-0.25

89.19%-0.32

105.04%0.20

162.54%3.53

91.52%-1.19

82.11%-2.93

77.04%-3.88

68.60%-5.65

22.66%-13.97

20.10%-16.40

-472.29%-16.92

17.78%-17.98

24.56%-18.07

9.23%-20.53

119.99%4.54

-2.12%-21.87

-0.60%-23.95

1.24%-22.61

20.20%-22.73

28.68%-21.41

30.00%-23.81

30.04%-22.90

28.83%-28.49

16.40%-30.02

22.13%-34.01

-1.85%-32.73

-39.64%-40.02

-37.25%-35.91

-51.69%-43.67

-25.96%-32.13

-22.26%-28.66

-18.54%-26.17

-82.64%-28.79

-15.83%-25.51

-42.39%-23.45

-52.17%-22.07

15.57%-15.76

-105.43%-22.02

-6.76%-16.47

-38.84%-14.51

64.63%-18.67

-46.45%-10.72

-165.37%-15.42

-15.03%-10.45

---52.79

---7.32

-226.16%-5.81

-443.03%-9.08

---1.78

---1.67

稀釋每股收益

-108.40%-0.29

78.90%-0.25

89.19%-0.32

104.99%0.19

162.04%3.50

91.52%-1.19

82.11%-2.93

77.04%-3.88

68.60%-5.65

22.66%-13.97

20.10%-16.40

-473.25%-16.92

17.78%-17.98

24.56%-18.07

9.23%-20.53

119.94%4.53

-2.12%-21.87

-0.60%-23.95

1.24%-22.61

20.20%-22.73

28.68%-21.41

30.00%-23.81

30.04%-22.90

28.83%-28.49

16.40%-30.02

22.13%-34.01

-1.85%-32.73

-39.64%-40.02

-37.25%-35.91

-51.69%-43.67

-25.96%-32.13

-22.26%-28.66

-18.54%-26.17

-82.64%-28.79

-15.83%-25.51

-42.39%-23.45

-52.17%-22.07

15.57%-15.76

-105.43%-22.02

-6.76%-16.47

-38.84%-14.51

64.63%-18.67

-46.45%-10.72

-165.37%-15.42

-15.03%-10.45

---52.79

---7.32

-226.16%-5.81

-443.03%-9.08

---1.78

---1.67

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Atara Biotherapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 ATRA 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Atara Biotherapeutics Inc 財年末的營收是多少？



Atara Biotherapeutics Inc 2025 財年營收為 120.77M，高於上一財年的 128.94M。

Atara Biotherapeutics Inc 最近一個季度的營收是多少？



Atara Biotherapeutics Inc 最近一個季度的營收為 516.00K，同比增長 -99.47%。

Atara Biotherapeutics Inc 全年的淨利潤是多少？



Atara Biotherapeutics Inc 2025 財年淨利潤為 32.69M。

Atara Biotherapeutics Inc 上一季度的淨利潤是多少？



Atara Biotherapeutics Inc 最近一個季度的淨利潤為 -4.14M。

Atara Biotherapeutics Inc 年度營業利潤是多少？



Atara Biotherapeutics Inc 2025 財年的營業利潤為 52.57M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。